Physician profile
Jeffrey M Delott
NPI 1194712349
$3,936.51
in general payments reported to CMS, 2019-2025
15 companies · $1,104 in 2025
The $1,104 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,402 · 2020: $49.01 · 2022: $12.35 · 2023: $952 · 2024: $416 · 2025: $1,104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,237 · Travel and Lodging: $1,236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,236.51 |
| Travel and Lodging | $1,236.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,228.43 | 2023-2025 | |
| Medical Device Business Services, INC. | $927.49 | 2019 | |
| International Life Sciences | $584.07 | 2023 | |
| Depuy Synthes Sales INC. | $317.18 | 2019-2025 | Monovisc, Orthovisc, Dynacord |
| Gramercy Extremity Orthopedics LLC | $255.80 | 2023 | |
| Celularity INC. | $203.00 | 2019 | |
| Medshape, INC. | $182.88 | 2024 | Dynanail Helix, Washer, 15 Mm, Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm |
| Stryker Corporation | $71.68 | 2019 | |
| Endo Pharmaceuticals INC. | $55.94 | 2019-2024 | Xiaflex |
| Pacira Pharmaceuticals Incorporated | $23.10 | 2025 | Exparel, Iovera, Zilretta |
| Bioventus LLC | $21.65 | 2025 | Gelsyn-3 |
| Smith+Nephew, INC. | $20.80 | 2025 | Renasys Touch |
| Polaris Technology Solutions LLC | $16.76 | 2025 | |
| Ferring Pharmaceuticals INC. | $15.38 | 2024 | Euflexxa |
| Horizon Therapeutics Plc | $12.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Delott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.